Etid klinik pou Limfom nan Nebraska
7 etid pou Limfom ap chèche patisipan nan sit nan Nebraska.
Vil nan Nebraska
Tèks ofisyèl etid la (Anglè)
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- University of Nebraska Medical Center, Omaha
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT05826535Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant
- University of Nebraska Medical Center, Omaha
Ap rekrite
Laj 19 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT04898790A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
- University of Nebraska Medical Center, Omaha
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT06528301A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
- University of Nebraska Medical Center (UNMC), Omaha
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 4, 2026 · NCT07188558Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Cellular Therapy
- Unversity of Nebraska Medical Center, Omaha
Ap rekrite
Laj 19 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT05135351CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- Fred and Pamela Buffett Cancer Center, Omaha
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Apr 16, 2026 · NCT03328078The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
- Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha
Ap rekriteFaz 1/2
Laj 12 a 95 · Tout sèks · Mizajou Apr 15, 2026 · NCT04329728Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.